The Tyrosine Kinase Inhibitor Gefitinib Restricts Mycobacterium tuberculosis Growth through Increased Lysosomal Biogenesis and Modulation of Cytokine Signaling.
Saved in:
| Title: | The Tyrosine Kinase Inhibitor Gefitinib Restricts Mycobacterium tuberculosis Growth through Increased Lysosomal Biogenesis and Modulation of Cytokine Signaling. |
|---|---|
| Authors: | Sogi KM; School of Public Health, Division of Infectious Diseases and Vaccinology, Li Ka Shing Center, University of California , Berkeley, California 94720, United States., Lien KA; Department of Molecular and Cell Biology, University of California , Berkeley, California 94720, United States., Johnson JR; Department of Cellular and Molecular Pharmacology, University of California-San Francisco , San Francisco, California 94158, United States., Krogan NJ; Department of Cellular and Molecular Pharmacology, University of California-San Francisco , San Francisco, California 94158, United States., Stanley SA; School of Public Health, Division of Infectious Diseases and Vaccinology, Li Ka Shing Center, University of California , Berkeley, California 94720, United States.; Department of Molecular and Cell Biology, University of California , Berkeley, California 94720, United States. |
| Source: | ACS infectious diseases [ACS Infect Dis] 2017 Aug 11; Vol. 3 (8), pp. 564-574. Date of Electronic Publication: 2017 Jun 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: ACS Publications Country of Publication: United States NLM ID: 101654580 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2373-8227 (Electronic) Linking ISSN: 23738227 NLM ISO Abbreviation: ACS Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
